Home > Qtrly Results > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Quarterly Results Analysis [Dec2025]

AD     Remove this Ad

KILITCH DRUGS (INDIA) Quarterly Results

Consolidated Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Revenues ₹54 Cr ₹49 Cr ₹43 Cr ₹61 Cr ₹56 Cr ₹47 Cr ₹33 Cr ₹45 Cr
Expenses ₹48 Cr ₹44 Cr ₹40 Cr ₹47 Cr ₹47 Cr ₹41 Cr ₹32 Cr ₹38 Cr
Operating Income ₹6 Cr ₹5 Cr ₹3 Cr ₹15 Cr ₹9 Cr ₹6 Cr ₹2 Cr ₹7 Cr
Other Income ₹2 Cr ₹7 Cr ₹3 Cr ₹2 Cr ₹2 Cr ₹5 Cr ₹3 Cr ₹0 Cr
Interest ₹1 Cr ₹1 Cr ₹2 Cr ₹2 Cr ₹1 Cr ₹0 Cr ₹2 Cr ₹1 Cr
Depreciation ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr
Profit Before Tax ₹6 Cr ₹9 Cr ₹3 Cr ₹14 Cr ₹8 Cr ₹10 Cr ₹2 Cr ₹5 Cr
Profit After Tax ₹4 Cr ₹8 Cr ₹2 Cr ₹10 Cr ₹6 Cr ₹9 Cr ₹0 Cr ₹4 Cr
EPS ₹2.54 ₹4.69 ₹1.84 ₹6.33 ₹3.63 ₹5.24 ₹0.82 ₹2.19
Industry Peers & Returns1W1M1Y
KILITCH DRUGS (INDIA) -12.7% -14% -12.4%
SUN PHARMACEUTICAL INDUSTRIES 1% 3.8% 0.6%
DIVIS LABORATORIES -1.7% -4.1% 3.8%
CIPLA -1.1% -6.3% -18.3%
TORRENT PHARMACEUTICALS -0% -3% 33.3%
DR REDDYS LABORATORIES -1.3% -1.3% 8.6%
MANKIND PHARMA 2% -0.6% -16.4%
ZYDUS LIFESCIENCES 0.7% -0.9% -1.6%
LUPIN 0.5% 3.7% 11%

KILITCH DRUGS (INDIA) Quarterly Revenues

Revenues
Q-o-Q

9.98 %

Y-o-Y

-4.20 %

Quarters Revenues % Change
Dec2025 ₹54 Cr
9.98
Sep2025 ₹49 Cr
13.41
Jun2025 ₹43 Cr
-29.54
Mar2025 ₹61 Cr
9.01
Dec2024 ₹56 Cr
18.31
Sep2024 ₹47 Cr
41.92
Jun2024 ₹33 Cr
-25.36
Mar2024 ₹45 Cr -

KILITCH DRUGS (INDIA) Quarterly Operating Profit

Operating Profit
Q-o-Q

22.06 %

Y-o-Y

-29.57 %

Quarters Operating Profit % Change
Dec2025 ₹6 Cr
22.06
Sep2025 ₹5 Cr
54.41
Jun2025 ₹3 Cr
-77.63
Mar2025 ₹15 Cr
67.07
Dec2024 ₹9 Cr
43.36
Sep2024 ₹6 Cr
267.05
Jun2024 ₹2 Cr
-76.55
Mar2024 ₹7 Cr -
Operating Margins
Q-o-Q

10.97 %

Y-o-Y

-26.50 %

Quarters Operating Margin% % Change
Dec2025 11.43%
10.97
Sep2025 10.3%
36.06
Jun2025 7.57%
-68.25
Mar2025 23.84%
53.31
Dec2024 15.55%
21.20
Sep2024 12.83%
158.67
Jun2024 4.96%
-68.59
Mar2024 15.79% -

KILITCH DRUGS (INDIA) Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-46.32 %

Y-o-Y

-23.12 %

Quarters Profit After Tax % Change
Dec2025 ₹4 Cr
-46.32
Sep2025 ₹8 Cr
255.55
Jun2025 ₹2 Cr
-77.87
Mar2025 ₹10 Cr
82.06
Dec2024 ₹6 Cr
-34.82
Sep2024 ₹9 Cr
7,588.39
Jun2024 ₹0 Cr
-96.96
Mar2024 ₹4 Cr -
PAT Margins
Q-o-Q

-51.19 %

Y-o-Y

-19.72 %

Quarters PAT Margin(%) % Change
Dec2025 8.02 %
-51.19
Sep2025 16.43 %
213.55
Jun2025 5.24 %
-68.60
Mar2025 16.69 %
67.07
Dec2024 9.99 %
-44.93
Sep2024 18.14 %
5,396.97
Jun2024 0.33 %
-95.99
Mar2024 8.22 % -

KILITCH DRUGS (INDIA) Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-45.84 %

Y-o-Y

-30.03 %

Quarters EPS % Change
Dec2025 ₹2.54
-45.84
Sep2025 ₹4.69
154.89
Jun2025 ₹1.84
-70.93
Mar2025 ₹6.33
74.38
Dec2024 ₹3.63
-30.73
Sep2024 ₹5.24
539.02
Jun2024 ₹0.82
-62.56
Mar2024 ₹2.19 -

You may also like the below Video Courses